Jesse A Davidson1, Tracy T Urban2, Christine Baird3, Suhong Tong4, Alan Woodruff5, Mark Twite6, James Jaggers7, Eric A F Simões3, Paul Wischmeyer8. 1. Department of Pediatrics, Children's Hospital Colorado/University of Colorado, Denver, Aurora, CO. Electronic address: jesse.davidson@childrenscolorado.org. 2. Research Institute, Children's Hospital Colorado, Aurora, CO. 3. Department of Pediatrics, Children's Hospital Colorado/University of Colorado, Denver, Aurora, CO. 4. Department of Biostatistics, University of Colorado, Denver, Aurora, CO. 5. Division of Pediatric Critical Care Medicine, Boston Children's Hospital, Department of Anesthesia, Boston, MA; Harvard Medical School, Boston, MA. 6. Department of Anesthesiology, Children's Hospital Colorado/University of Colorado, Denver, Aurora, CO. 7. Department of Surgery, Children's Hospital Colorado/University of Colorado, Denver, Aurora, CO. 8. Department of Anesthesiology, Duke University, Durham, NC.
Abstract
OBJECTIVES: To determine the kinetics of alkaline phosphatase (AP) activity and concentration after infant cardiopulmonary bypass, including isoform-specific changes, and to measure the association between postoperative AP activity and major postoperative cardiovascular events, organ injury/dysfunction, and postoperative support requirements STUDY DESIGN: Prospective cohort study of 120 infants ≤120 days of age undergoing cardiopulmonary bypass. AP total and isoform-specific activity was assessed at 6 time points (preoperation, rewarming, 6, 24, 48, and 72 hours postoperation). Low AP activity was defined as ≤80 U/L. AP concentrations and biomarkers of organ injury/dysfunction were collected through 24 hours postoperation. Major cardiovascular events were defined as cardiac arrest, mechanical circulatory support, or death. RESULTS: AP activity loss occurred primarily during the operation (median decrease 89 U/L; P < .0001) secondary to decreased bone and liver 2 isoforms. Activity declined through 24 hours in 27% of patients. AP activity strongly correlated with serum concentration (r = 0.87-0.91; P < .0001). Persistent low AP activity at 72 hours was associated independently with occurrence of a major cardiac event (OR 5.6; P < .05). Early AP activity was associated independently with subsequent vasoactive-inotropic score (P < .001), peak lactate (P < .0001), peak creatinine (P < .0005), N-terminal pro-brain natriuretic peptide (P < .05), and intestinal fatty acid binding protein (P < .005). CONCLUSIONS: AP activity decreases during infant cardiopulmonary bypass and may continue to decrease for 24 hours. Activity loss is secondary to decreased bone and liver 2 isoform concentrations. Early low AP activity is associated independently with subsequent postoperative support and organ injury/dysfunction, and persistence of AP activity ≤80 U/L at 72 hours is associated independently with increased odds of major cardiovascular events.
OBJECTIVES: To determine the kinetics of alkaline phosphatase (AP) activity and concentration after infant cardiopulmonary bypass, including isoform-specific changes, and to measure the association between postoperative AP activity and major postoperative cardiovascular events, organ injury/dysfunction, and postoperative support requirements STUDY DESIGN: Prospective cohort study of 120 infants ≤120 days of age undergoing cardiopulmonary bypass. AP total and isoform-specific activity was assessed at 6 time points (preoperation, rewarming, 6, 24, 48, and 72 hours postoperation). Low AP activity was defined as ≤80 U/L. AP concentrations and biomarkers of organ injury/dysfunction were collected through 24 hours postoperation. Major cardiovascular events were defined as cardiac arrest, mechanical circulatory support, or death. RESULTS: AP activity loss occurred primarily during the operation (median decrease 89 U/L; P < .0001) secondary to decreased bone and liver 2 isoforms. Activity declined through 24 hours in 27% of patients. AP activity strongly correlated with serum concentration (r = 0.87-0.91; P < .0001). Persistent low AP activity at 72 hours was associated independently with occurrence of a major cardiac event (OR 5.6; P < .05). Early AP activity was associated independently with subsequent vasoactive-inotropic score (P < .001), peak lactate (P < .0001), peak creatinine (P < .0005), N-terminal pro-brain natriuretic peptide (P < .05), and intestinal fatty acid binding protein (P < .005). CONCLUSIONS: AP activity decreases during infant cardiopulmonary bypass and may continue to decrease for 24 hours. Activity loss is secondary to decreased bone and liver 2 isoform concentrations. Early low AP activity is associated independently with subsequent postoperative support and organ injury/dysfunction, and persistence of AP activity ≤80 U/L at 72 hours is associated independently with increased odds of major cardiovascular events.
Authors: S K Ohri; I Bjarnason; V Pathi; S Somasundaram; C T Bowles; B E Keogh; A Khaghani; I Menzies; M H Yacoub; K M Taylor Journal: Ann Thorac Surg Date: 1993-05 Impact factor: 4.330
Authors: Michael G Gaies; James G Gurney; Alberta H Yen; Michelle L Napoli; Robert J Gajarski; Richard G Ohye; John R Charpie; Jennifer C Hirsch Journal: Pediatr Crit Care Med Date: 2010-03 Impact factor: 3.624
Authors: Peter Pickkers; Suzanne Heemskerk; Jeroen Schouten; Pierre-François Laterre; Jean-Louis Vincent; Albertus Beishuizen; Philippe G Jorens; Herbert Spapen; Michael Bulitta; Wilbert H M Peters; Johannes G van der Hoeven Journal: Crit Care Date: 2012-01-23 Impact factor: 9.097
Authors: Matthew Pettengill; Simon Robson; Megan Tresenriter; José Luis Millán; Anny Usheva; Taiese Bingham; Mirjam Belderbos; Ilana Bergelson; Sarah Burl; Beate Kampmann; Laura Gelinas; Tobias Kollmann; Louis Bont; Ofer Levy Journal: J Biol Chem Date: 2013-07-29 Impact factor: 5.157
Authors: Jelena Klawitter; Jesse Davidson; Evan Pagano; Benjamin Frank; James Jaggers; Mark Twite; Tracy T Urban Journal: Congenit Heart Dis Date: 2020-09-07 Impact factor: 2.007
Authors: Jesse A Davidson; Tracy T Urban; Suhong Tong; Aline Maddux; Gerald Hill; Benjamin S Frank; John D Watson; James Jaggers; Eric A F Simões; Paul Wischmeyer Journal: Shock Date: 2019-03 Impact factor: 3.454
Authors: Jesse A Davidson; Benjamin S Frank; Tracy T Urban; Mark Twite; James Jaggers; Ludmila Khailova; Jelena Klawitter Journal: Pediatr Nephrol Date: 2021-05-05 Impact factor: 3.651
Authors: Jesse A Davidson; Zachary Pfeifer; Benjamin Frank; Suhong Tong; Tracy T Urban; Paul A Wischmeyer; Peter Mourani; Bruce Landeck; Uwe Christians; Jelena Klawitter Journal: J Am Heart Assoc Date: 2018-12-18 Impact factor: 5.501
Authors: Thomas Poschner; Anne-Kristin Schaefer; Doris Hutschala; Georg Goliasch; Julia Riebandt; Klaus Distelmaier; Martin H Bernardi; Martin Andreas; Ruud Brands; Tandis Aref; Günther Laufer; Dominik Wiedemann Journal: Biomolecules Date: 2021-05-17
Authors: Jessica N Persson; Christine H Baird; Suhong Tong; Tracy T Urban; Jelena Klawitter; Paul E Wischmeyer; Jesse A Davidson Journal: Pediatr Res Date: 2018-01-17 Impact factor: 3.756
Authors: John D Watson; Tracy T Urban; Suhong S Tong; Jeanne Zenge; Ludmilla Khailova; Paul E Wischmeyer; Jesse A Davidson Journal: Front Pediatr Date: 2020-05-27 Impact factor: 3.418